The potential of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide to circumvent three multidrug-resistance phenotypes in vitro

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 5, 1997, Pages 424-430

  Davey, Ross A ^a   Su, Gloria M ^a   Hargrave, Rebecca M ^b   Harvie, Rozelle M ^a   Baguley, Bruce C ^c   Davey, Mary W ^b  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

DACA; Idarubicin; MRP; Multidrug resistance; P glycoprotein; Paclitaxel

Indexed keywords

AMSACRINE; BUTHIONINE SULFOXIMINE; DAUNORUBICIN; GLYCOPROTEIN P; IDARUBICIN; N (2 DIMETHYLAMINOETHYL) 4 ACRIDINECARBOXAMIDE; PACLITAXEL; VERAPAMIL;

ARTICLE; CELL STRAIN HL 60; CELL STRAIN K 562; CYTOTOXICITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL;

ACRIDINES; AMSACRINE; ANTINEOPLASTIC AGENTS; BUTHIONINE SULFOXIMINE; CELL LINE; CELL SURVIVAL; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; HL-60 CELLS; HUMANS; IDARUBICIN; LEUKEMIA; P-GLYCOPROTEIN; PACLITAXEL; PHENOTYPE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0031040159     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050593     Document Type: Article

References (27)

1. Atwell GJ, Rewcastle GW, Baguley BC, Denny WA (1987) Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. J Med Chem 30:664-669
2. Beck W, Mueller T, Tanzer L (1979) Altered surface membrane glycoproteins in vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res 39:2070-2076
3. Berman E (1993) A review of idarubicin in acute leukemia. Oncology 7:91-104
4. Berman E, McBride M (1992) Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells. Blood 79:3267-3273
5. Chomcyznski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
6. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654
7. Cole SP, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM, Deeley RG (1994) Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54:5902-5910
8. Davey R, Longhurst T, Davey M, Belov L, Harvie R, Hancox D, Wheeler H (1995) Drug resistance mechanisms and MRP expression in response to epirubicin treatment in a human leukaemia cell line. Leuk Res 19:275-282
9. Davey MW, Margrave RM, Davey RA (1996) Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells. Leuk Res (in press)
10. Finlay GJ, Marshall E, Matthews JH, Paull KD, Baguley BC (1993) In vitro assessment of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide, a DNA-intercalating antitumour drug with reduced sensitivity to multidrug resistance. Cancer Chemother Pharmacol 31 :401-406
11. Finlay GJ, Riou JF, Baguley BC (1996) From amsacrine to daca (N-[2-(dimethylamino)ethyl]acridine-4-carboxamide) selectivity for topoisomerases I and II among acridine derivatives. Eur J Cancer 32A: 708-714
12. Foley G, Lazarus H, Farber S, Uzman B, Boone B, McCarthy R (1965) Continuous culture of human lymphoblasts from peritoneal blood of a child with acute leukemia. Cancer 18:522-529
13. Gallagher R, Collins S, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar R, Aulakh G, Ting R, Ruscetti F, Gallo R (1979) Characterisation of the continuous, differentiating myeloid cell line (HL60) from a patient with promyelocytic leukemia. Blood 54:713-733
14. Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427
15. Hargrave R, Davey M, Davey R, Kidman A (1995) Development of drug resistance is reduced with idarubicin relative to other anlhracyclines. Anticancer Drugs 6:432 437
16. Jedlitschky G, Leier I, Buchholz U, Center M, Keppler D (1994) ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54:4833-4836
17. Leier I, Jedlitschky G, Buchholz U, Cole SP, Deeley RG, Keppler D (1994) The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269:27807-27810
18. Lozzio C, Lozzio B (1975) Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Proc Soc Exp Biol Med 166:546-550
19. Marks DC, Belov L, Davey MW, Davey RA, Kidman AD (1992) The MTT cell viability assay for cytotoxicity testing in multidrug-resistant human leukemic cells. Leuk Res 16:1165-1173
20. Marks DC, Davey MW, Davey RA, Kidman AD (1993) Differentiation and multidrug resistance in response to drug treatment in the K562 human leukaemia cell line. Br J Haematol 84:83-89
21. Paxton JW, Young D, Robertson IG (1993) Pharmacokinetics of acridine-4-carboxamide in the rat, with extrapolation to humans. Cancer Chemother Pharmacol 32:323 325
22. Schneider E, Darkin SJ, Lawson PA, Ching LM, Ralph RK, Baguley BC (1988) Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)-ethyl]acridine-4-carboxamide: role of DNA topoisomerase II. Eur J Cancer Clin Oncol 24:1783 1790
23. Shambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor, New York
24. Su GM, Davey MW, Davey RA, Kidman AD (1994) Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells. Br J Haematol 88:566 574
25. Tidfelt U, Sundman-Engberg B, Paul C (1994) Comparison of the intracellular pharmacokinetics of daunorubicin and idarubicin in patients with acute leukemia. Leuk Res 18:293 297
26. Versantvoort CH, Broxterman HJ, Bugrij T, Scheper RJ, Twentyman PR (1995) Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br J Cancer 72:82 89
27. Zaman GJ, Flens MJ, Leusden MR van, Haas M de, Mulder HS, Lankelma J, Pinedo HM, Scheper RJ, Baas F, Broxterman HJ, Borst P (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci USA 91 :8822 8826